News

PRADA: Candesartan prevents LVEF decline in women treated for breast cancer

16.11.20152691

In women treated for early breast cancer, the angiotensin receptor blocker candesartan protected against a decline in left ventricular ejection fraction, but the beta-blocker metoprolol did not, researchers reported here.

Conversion from AF to sinus rhythm shorter, more effective with vernakalant vs. ibutilide

13.11.20152205

Patients with atrial fibrillation who received the novel antiarrthyhmic drug vernakalant had faster conversion time to sinus rhythm and greater conversion success than patients assigned ibutilide.

Abstract submission to the EAS Congress 2016 is open!

12.11.20151861

Be part of EAS 2016 - an outstanding scientific programme covering recent developments in the field of atherosclerosis-related disease and clinical therapies.

Dyspnea, bleeding most common causes of ticagrelor discontinuation

12.11.20152090

The most frequent causes of ticagrelor discontinuation in the PEGASUS?TIMI 54 study were dyspnea and bleeding, and many of those events were minor, according to results of a substudy presented at the American Heart Association Scientific Sessions.

Russian Journal of Cardiology is now available in English

11.11.20152343

In 2016 articles both original and already published and translated into English can be submitted to the Russian Journal of Cardiology.

Russian Journal of Cardiology is going to issue in 2016

11.11.20152165

Russian Journal of Cardiology is going to issue in 2016 ESC guidelines and textbook.

FDA: No Raised Mortality, Cancer Risk With Long-Term Clopidogrel

11.11.20151829

The announcement was based on a review of the Dual Antiplatelet Therapy (DAPT) trial, as well as of other large clinical trials that also examined adverse events from clopidogrel use.